Effect of Immune Deficiency on Lipoproteins and Atherosclerosis in Male Apolipoprotein E-deficient Mice
Overview
Affiliations
To determine whether T cells and B cells influence lipid metabolism and atherosclerosis, we crossed apolipoprotein E-deficient (apoE degrees ) mice with recombination activating gene 2-deficient (RAG2 degrees ) mice. Total plasma cholesterol levels were approximately 20% higher in male apoE degrees mice compared with the apoE degrees RAG2 degrees mice at 8 weeks of age, and plasma triglyceride levels were 2.5-fold higher in the apoE degrees mice even when plasma cholesterol levels were similar. Male mice with plasma cholesterol levels between 400 and 600 mg/dL at 8 weeks of age were euthanized at 27 and 40 weeks of age. The aortic root lesion area in the apoE degrees RAG2 degrees mice, compared with that in the immune-competent apoE degrees mice, was 81% and 57% smaller at 27 and 40 weeks of age, respectively. In contrast, there was no difference in the size of the brachiocephalic trunk lesions. Similar results were obtained with mice euthanized at 40 weeks of age that had 8-week cholesterol levels between 300 and 399 mg/dL. In apoE degrees RAG2 degrees mice, aortic root atherosclerosis was more profoundly suppressed at lower cholesterol levels. Thus, T and B cells and their products differentially influence the development of atherosclerosis at different sites. We also demonstrate a profound effect of the immune system on plasma lipid homeostasis.
Atherosclerosis antigens as targets for immunotherapy.
Raposo-Gutierrez I, Rodriguez-Ronchel A, Ramiro A Nat Cardiovasc Res. 2024; 2(12):1129-1147.
PMID: 39196152 DOI: 10.1038/s44161-023-00376-x.
Sircana M, Erre G, Castagna F, Manetti R Life (Basel). 2024; 14(6).
PMID: 38929699 PMC: 11204900. DOI: 10.3390/life14060716.
Insights from Murine Studies on the Site Specificity of Atherosclerosis.
Getz G, Reardon C Int J Mol Sci. 2024; 25(12).
PMID: 38928086 PMC: 11204064. DOI: 10.3390/ijms25126375.
Barrero-Rodriguez R, Rodriguez J, Tarifa R, Vazquez J, Mastrangelo A, Ferrarini A Front Mol Biosci. 2022; 9:952149.
PMID: 36158581 PMC: 9493301. DOI: 10.3389/fmolb.2022.952149.
Bellini R, Bonacina F, Norata G Front Cardiovasc Med. 2022; 9:934314.
PMID: 35966516 PMC: 9365967. DOI: 10.3389/fcvm.2022.934314.